66 postdoc-in-distributed-systems-and-controls-"Multiple" Fellowship positions at University of Nottingham
Sort by
Refine Your Search
-
into politics and crime. The research is funded by the Leverhulme Trust. The School and the University more widely is determined to provide a diverse and inclusive environment for staff and students which draws
-
Dependent type theory is a foundation of mathematics that allows us to mechanise arguments, and is closely related to higher category theory. It serves as that basis of programming languages and
-
style education has grown to establish a student body of over 9,000 in just 20 years. The University of Nottingham Ningbo, China, a pioneer in Sino-foreign tertiary education, is rapidly expanding. It is
-
to include: Conducting, coding, and analysing key informant interviews focused on justice system performance and confidence Disseminating, processing, and analysing key informant surveys focused on justice
-
Group. The role will provide an opportunity to work across multiple projects within the realms of Artificial Intelligence and Digital Screening. The role holder will collaborate with cross-functional
-
fidelity software-based simulation tools to advance the design, optimisation and manufacture of magnetic field shielding and control systems for a diverse range of applications. These field control
-
We are looking for a researcher, whose expertise lies in numerical methods for dynamical systems, to work with Dr Rachel Nicks and Professor Stephen Coombes on a Leverhulme Trust - funded project
-
, alignment, and characterisation of laser-based instrumentation. • Strong experience with computer programming, both for signal processing and experimental hardware control (e.g., C, C++, Python, MATLAB
-
Nottingham University Business School China Dr Jie Yu (Joseph)’s research team is seeking outstanding Postdoctoral Research Fellow to join the postdoctoral research station in business
-
Pancreatic cancer is a devastating disease affecting 500,000 people globally each year, including over 10,000 in the UK, with a mere 5% ten-year survival rate. Our goal is to accelerate the clinical